Comparative Efficacy of Ormeloxifene and Progestogens in the Management of Abnormal Uterine Bleeding - nil

Department of Obstetrics and gynaecology0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年6月24日

试验速览

暂无简介。

•Women of age >35 years presenting to the Gynaecological OPD with complaint of prolonged, heavy or irregular bleeding per vaginum who have been diagnosed with benign structural causes of Abnormal Uterine Bleeding such as adenomyosis and leiomyoma.

•1.Uterine/endocervical polyp
•2.Women in whom endometrial biopsy shows a histopathology diagnosis of proliferative endometrium, endometrial hyperplasia, or malignancy.
•3.Women with contraindications for treatment with progestogens
•4.Women with previously failed medical management.
•5.Women with active genital infection.
•6.Women with abnormal renal or hepatic function tests, deranged coagulation profile, endocrinological or any other systemic illness that can cause Abnormal Uterine Bleeding.
•7.Women complaining of infertility.

发起方

Department of Obstetrics and gynaecology